P

Inventor

SAH DINAH W Y

US14 patents
⚠️ This page may combine multiple inventors who share the name “SAH DINAH W Y”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV YALE

4 patents
US7173118B2Feb 6, 2007

Nogo receptor homologs

UNIV YALE20 citations92
US7465705B2Dec 16, 2008

Nogo receptor antagonists

UNIV YALE37 citations90
US7456255B2Nov 25, 2008

Nogo receptor homologs that decrease inhibition of axonal elongation

UNIV YALE8 citations71
US8030456B2Oct 4, 2011

Nogo receptor antagonists

UNIV YALE2 citations60

BIOGEN IDEC INC

2 patents
US7655463B2Feb 2, 2010

Methods of activating RET receptor tyrosine kinase using neurotrophic factors

BIOGEN IDEC INC24 citations92
US7358228B2Apr 15, 2008

Methods of treating pain using neurotrophic factors

BIOGEN IDEC INC23 citations92

SIGNAL PHARM INC

2 patents
US6225122B1May 1, 2001

Human spinal cord cell lines and methods of use therefor

SIGNAL PHARM INC16 citations83
US6835567B1Dec 28, 2004

PNS cell lines and methods of use therefor

SIGNAL PHARM INC15 citations82

SAH DINAH W Y

2 patents
US8217146B2Jul 10, 2012

Neurotrophic factors and methods of use thereof

SAH DINAH W Y4 citations70
US8957038B2Feb 17, 2015

Treatment of neurological disorders

SAH DINAH W Y0 citations40

NSGENE AS

1 patent
US7276580B2Oct 2, 2007

Neurotrophic factors

NSGENE AS24 citations91

COREY DAVID R

1 patent
US9574191B2Feb 21, 2017

Selective inhibition of polyglutamine protein expression

COREY DAVID R6 citations71

SIGNAL PHARM LLC

1 patent
US6913925B1Jul 5, 2005

Human mesencephalon cell lines and methods of use therefor

SIGNAL PHARM LLC9 citations71

SIGNAL PHARMACEUTICIALS INC

1 patent
US6713247B1Mar 30, 2004

Human CNS cell lines and methods of use therefor

SIGNAL PHARMACEUTICIALS INC5 citations57